Announcements Trials
Browse Landscape

Phase

Phase 2 73Phase 1 45Phase 1/2 33Phase 3 27Phase 2/3 4Phase NA 3Phase EARLY_PHASE1 1Phase 4 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Immunoglobulin Light-chain Amyloidosis 1

Interventions

Standard of Care 72Educational Status 60Methods 55Interviews as Topic 55Early Intervention, Educational 53Practice Guidelines as Topic 52Exercise 50Blood Specimen Collection 49Magnetic Resonance Spectroscopy 48Surveys and Questionnaires 47Specimen Handling 40Radiosurgery 31Palliative Care 24Radiotherapy 23Biopsy 20Magnetic Resonance Imaging 16Patient Navigation 15Resistance Training 14Counseling 14Exercise Test 13Diet Therapy 13Therapeutics 11Health Promotion 11Surgical Procedures, Operative 10Referral and Consultation 10Radiation Dose Hypofractionation 10Proton Therapy 10Drug Therapy 10X-Rays 9Telemedicine 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × venetoclax × 90 days × Clear all
NCT07454226 2026-05-13

ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL

Institute of Hematology & Blood Diseases Hospital, China

Phase NA Recruiting
92 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07495631 2026-05-13

Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia

Institute of Hematology & Blood Diseases Hospital, China

Phase NA Recruiting
43 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06192979 2026-03-09

Optimize First-line Treatment for AL Amyloidosis With t (11; 14)

Peking University People's Hospital

Phase NA Recruiting
41 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡